Amanote Research
Register
Sign In
RIPK3: Beyond Necroptosis
Immunity
- United States
doi 10.1016/j.immuni.2018.12.031
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Allergy
Immunology
Date
January 1, 2019
Authors
Azia S. Evans
Carolyn B. Coyne
Publisher
Elsevier BV
Related search
Kinase Domain Dimerization Drives RIPK3-dependent Necroptosis
Science Signaling
Biochemistry
Cell Biology
Molecular Biology
Absence of RIPK3 Predicts Necroptosis Resistance in Malignant Melanoma
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
RIPK1 Both Positively and Negatively Regulates RIPK3 Oligomerization and Necroptosis
Cell Death and Differentiation
Cell Biology
Molecular Biology
RIPK3/Fas-Associated Death Domain Axis Regulates Pulmonary Immunopathology to Cryptococcal Infection Independent of Necroptosis
Frontiers in Immunology
Allergy
Immunology
RIPK3-Mediated Necroptosis and Neutrophil Infiltration Are Associated With Poor Prognosis in Patients With Alcoholic Cirrhosis
Journal of Immunology Research
Medicine
Allergy
Immunology
Angiotensin II Triggers RIPK3-MLKL-mediated Necroptosis by Activating the Fas/FasL Signaling Pathway in Renal Tubular Cells
PLoS ONE
Multidisciplinary
Correction: High Mobility Group Box 1 Enables Bacterial Lipids to Trigger Receptor-Interacting Protein Kinase 3 (RIPK3)-mediated Necroptosis and Apoptosis in Mice.
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Axonal Degeneration Is Mediated by Necroptosis Activation Necroptosis Mediates Axonal Degeneration
Journal of Neuroscience
Neuroscience
Necroptosis in Cholangiocarcinoma
Cells